NMCAX
Price
$16.95
Change
-$0.30 (-1.74%)
Updated
Jul 13 closing price
Net Assets
577.72M
PAMCX
Price
$93.97
Change
-$0.37 (-0.39%)
Updated
Jul 13 closing price
Net Assets
22.63B
Interact to see
Advertisement

NMCAX vs PAMCX

NMCAX vs PAMCX Comparison Chart in %
View a ticker or compare two or three
VS
NMCAX vs. PAMCX commentary
Jul 14, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NMCAX is a Buy and PAMCX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
PAMCX has more cash in the bank: 22.6B vs. NMCAX (578M). NMCAX (0.00) and PAMCX (0.00) have matching dividends . NMCAX was incepted earlier than PAMCX: NMCAX (28 years) vs PAMCX (26 years). NMCAX (1.19) is less costly to investors than PAMCX (1.02). NMCAX is a more actively managed with annual turnover of: 87.00 vs. PAMCX (31.50). NMCAX has a lower initial minimum investment than PAMCX: NMCAX (1000) vs PAMCX (2500). PAMCX annual gain was more profitable for investors over the last year : -1.06 vs. NMCAX (-10.45). PAMCX return over 5 years is better than : -20.43 vs. NMCAX (-31.23).
NMCAXPAMCXNMCAX / PAMCX
Total Expense Ratio1.191.02117%
Annual Report Gross Expense Ratio1.191.02117%
Fund Existence28 years26 years-
Gain YTD9.4573.648259%
Front Load6%N/A-
Min. Initial Investment1000250040%
Min. Initial Investment IRAN/AN/A-
Net Assets578M22.6B3%
Annual Yield % from dividends0.000.00-
Returns for 1 year-10.45-1.06987%
Returns for 3 years-0.17-2.607%
Returns for 5 years-31.23-20.43153%
Returns for 10 years-22.8426.31-87%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
LZ7.720.47
+6.48%
LegalZoom.com
MCY110.361.10
+1.01%
Mercury General Corp
VRTX480.25-5.14
-1.06%
Vertex Pharmaceuticals
DUO0.61-0.02
-3.52%
Fangdd Network Group Ltd
ALXO1.97-0.15
-7.29%
ALX Oncology Holdings